Form 4 for MRNA Moderna
Accepted 2022-01-14 00:00:00 ET · period of report 2022-01-12 · accession 0001127602-22-001516 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-14 | 2022-01-12+ | MRNA | Hoge Stephen | Pres | M - OptEx | $5.95 | +20.0K | 1.61M | +1% | +$118.9K |
| DM | 2022-01-14 | 2022-01-12+ | MRNA | Hoge Stephen | Pres | S - Sale+OE | $219.67 | -20.0K | 1.61M | -1% | -$4.39M |
| DM | 2022-01-14 | 2022-01-12+ | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -20.0K | 167.4K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-13 | M | A | 5,000 | $10.90 | 1,614,597 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-12 | S | D | 5,000 | $220.01 | 1,609,597 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-13 | M | A | 10,000 | $0.99 | 1,624,597 | D | — | — | |
| 4 | Common | Common Stock | 2022-01-13 | S | D | 15,000 | $219.56 | 1,609,597 | D | — | — | |
| 5 | Common | Common Stock | 2022-01-12 | M | A | 5,000 | $10.90 | 1,614,597 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-01-13 | M | D | 5,000 | $0.00 | 156,972 | D | $10.90 · — to 2026-02-23 | 5,000 Common Stock | (F3) This option is fully vested and exercisable. |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-01-12 | M | D | 5,000 | $0.00 | 161,972 | D | $10.90 · — to 2026-02-23 | 5,000 Common Stock | (F3) This option is fully vested and exercisable. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-01-13 | M | D | 10,000 | $0.00 | 167,431 | D | $0.99 · — to 2023-08-19 | 10,000 Common Stock | (F3) This option is fully vested and exercisable. |